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An expression system for analysis of the synthesis and processing of the E2 glycoprotein of a hepatitis C virus (HCV) genotype 1a strain
was developed in transiently transfected cells. E2 proteins representing the entire length of the protein, including the transmembrane segment
(E2) as well as two truncated versions (E2660 and E2715), were characterized for acquisition of N-linked glycans and transport to the media of
transfected cells. To investigate the utilization of the 10 potential N-linked glycosylation sites on this E2 protein, a series of mutations
consisting of single or multiple (two, three, four or eight) ablations of asparagine residues in the background of the E2660 construct were
analyzed. E2660 proteins harboring single or multiple site mutations were produced at levels similar to that of wild-type protein, but secretion
of the single mutants was mildly diminished, and elimination of two or more sites dramatically reduced delivery of the protein to the media.
Similar results were obtained in Huh-7 cells with respect to intracellular synthesis and secretion of the mutant proteins. Analysis of
oligosaccharide composition using endoglycosidase digestion revealed that all of the glycan residues on the intracellular forms of E2660,
E2715, and E2 contained N-linked glycans modified into high-mannose carbohydrates, in contrast to the secreted forms, which were endo H
resistant. The parental E2660 protein could be readily detected in Huh-7 cells using anti-polyhistidine or antibody to recombinant E2. In
contrast, E2660 lacking the eight N-linked glycans was expressed but not detectable with anti-E2 antibody, and proteins lacking four glycans
exhibited reduced reactivity. These experiments provide direct evidence that the presence of multiple N-linked glycans is required for the
proper folding of the E2 protein in the ER and secretory pathway as well as for formation of its antigenic structure.
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Introduction linked glycans, whereas E2 is an approximately 65–70-kDaHepatitis C virus (HCV) encodes two envelope glyco-
proteins, E1 and E2, which form the major antigenic
components of the virion (Houghton, 2003). These proteins
contain many important biological activities, including
neutralizing antibody epitopes and binding determinants
for CD81, LDLr, and possibly other putative cellular recep-
tors involved in virus entry (Agnello et al., 1999; Flint et al.,
1999a; Gardner et al., 2003; Monazahian et al., 1999; Pileri
et al., 1998; Scarselli et al., 2002; Wunschmann et al.,
2000). E1 is a 31-kDa protein containing six potential N-0042-6822/$ - see front matter D 2003 Elsevier Inc. All rights reserved.
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E-mail address: chambetj@slu.edu (T.J. Chambers).protein, with as many as 11 potential N-linked sites
(Dubuisson et al., 1994; Op De Beeck et al., 2001). E1
and E2 are cotranslationally synthesized and processed in
association with the endoplasmic reticulum of host cells and
form two different types of complexes within the cell.
Covalent interactions involving interchain disulfide bonds
are believed to result in the formation of aggregated E1–E2
complexes which are probably targeted for degradation,
although their role in HCV pathogenesis remains unknown
(Dubuisson, 2000; Liberman et al., 1999). Noncovalently
associated E1–E2 complexes generated from properly
folded forms of these proteins are presumed to represent
prebudding structures that are ultimately incorporated into
mature virions (Deleersnyder et al., 1997; Ralston et al.,
1993; reviewed in Op De Beeck et al., 2001). Production of
the native complexes based on transient expression experi-
Fig. 1. Schematic of the E2 expression constructs designed for this study. Panel A indicates the structures of sigE2660, sigE2715, and sigE2 which were
engineered using the pcDNA3.1 expression vector. The carboxy termini of each construct also contain c-myc and polyhistidine tags (shaded regions). Panel B
indicates cell-free translation of E2715 with (S) or without (N) an amino-terminal signal sequence in the presence of microsomal membranes. Asterisk indicates
the glycosylated form of E2715. Arrowhead indicates the 30-kDa glycosylated form of alpha-factor. Arrow indicates the 32-kDa signal peptide precursor of beta
lactamase with the cleaved form immediately below. Panel C indicates the expression of the E2 proteins in BHK cells. M indicates mock-transfected cells. 746
indicates the E2 protein. Panel D indicates expression in BHK cells treated with tunicamycin. In panels C and D, cells were transfected, 35[S]-methionine
labeled proteins were immunoprecipitated and analyzed on 12% SDS polyacrylamide gels as described in the Materials and methods. MWs (kDa) were
determined with radioactive markers.
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formation compared to the folding and maturation of other
viral membrane glycoproteins (Doms et al., 1993; Dubuis-
son et al., 1994). Formation of these native and aggregated
complexes is a complicated process involving interactions
with calnexin, calreticulin, Bip, and perhaps other ER
chaperones (Choukhi et al., 1998; Dubuisson and Rice,
1996), as well as protein disulfide isomerase and peptidyl-
prolyl isomerases, which are implicated in early folding
events of proteins (Ellgaard and Helenius, 2003; Parodi,
2000). The E1 and E2 proteins are retained in the ER by
retention signals in their transmembrane domains, suggest-
ing that these regions are necessary for incorporation of the
proteins into the virion envelope within an intracellular
membrane compartment (Cocquerel et al., 1999, 2000;
Duvet et al., 1998). The exact location of virion assembly
and the precise modifications of E1 and E2, which are
required for this process, remain incompletely understood.
E1 and E2 proteins and virus-like particles have been
localized in association with intracellular membranes at
the level of the ER (Baumert et al., 1998; Dubuisson et
al., 1994; Martire et al., 2001). Transmembrane regions are
involved in the folding of E1, and E1–E2 complex forma-
tion (Cocquerel et al., 1998; Op De Beeck and Dubuisson,
2003; Patel et al., 2001), and some studies have shown that
the ectodomains of E1 and E2 participate in this process as
well (Patel et al., 2000; Yi et al., 1997). Precise molecular
determinants for many of these events and their importancefor the function and antigenicity of the E1–E2 complex
have been partially characterized (reviewed in Op De Beeck
and Dubuisson, 2003; Op De Beeck et al., 2001).
The E2 glycoprotein encodes as many as 11 N-linked
glycosylation sites, with previous studies suggesting that
many or all of these sites are utilized during posttransla-
tional processing of nascent E1–E2 complexes (Dubuis-
son et al., 1994; Lanford et al., 1993; Matsuura et al.,
1994; Spaete et al., 1992). N-linked oligosaccharide
addition is a common step in the maturation of viral
envelope glycoproteins and is often necessary for proper
folding of such proteins, either through effects on solu-
bility, stability, or by facilitating interactions with lectin-
binding chaperones that participate in folding of proteins
within the ER lumen (Doms et al., 1993). In some cases,
the precise position of an N-linked glycan is critical for
the proper folding of the viral protein, and elimination of
even a single site can abrogate normal processing (Helen-
ius, 1994). In the case of some viral proteins with
multiple N-linked sites such as the influenza hemaggluti-
nin and the simian virus 5 hemagglutinin/neuraminidae,
individual N-linked glycans can mediate important effects
on folding, oligomerization, transport, and aggregation
when analyzed with appropriate assays (Ng et al., 1990;
Roberts et al., 1993). In other cases, less dominant effects
have been observed (Gallagher et al., 1992). In addition to
assisting in the folding of antigenically complex proteins,
it is conceivable that multiple N-linked glycans may have
Fig. 2. Endoglycosidase digestion of E2 proteins. Proteins were isolated
from transfected cells by immunoprecipitation and subjected to digestion
with the endoglycosidases as described in Materials and methods. Tun, endo
F, and endo H indicate samples treated from cells treated with tunicamycin
or immunoprecipitates digested with endoglycosidase F or H, respectively.
Asterisks mark glycosidase digestion products for the E2 protein, for which
the protein bands are less intense than E2660 and E2715. 746 indicates the E2
protein. Top panel shows results for cell-associated forms of the E2 proteins.
Bottom panel shows digestion of E2 proteins recovered from the media. H
indicates samples digested with endoglycosidase H.
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with virus-specific antibodies, facilitating escape from
neutralization by antibodies, or complement, and interfer-Fig. 3. Schematic of the N-linked glycosylation mutants constructed in the E2660
indicates the additional potential N-linked glycosylation site found in the HVR-2ing with antigen processing. The observation that antige-
nicity of viral glycoproteins can in some cases be
enhanced by elimination of N-linked glycosylation sites
is consistent with these hypotheses (Fournillier et al.,
2001; Mori et al., 2001).
To gain further insight into the importance of N-linked
glycosylation of E2 for its synthesis and processing, we
constructed a series of mutants in which single or multiple
N-linked sites were abolished by site-directed mutagenesis
in the context of a truncated protein (E2660) containing the
first 276 amino acids of the E2 region. These mutants were
characterized by transient expression in cell culture to
determine which potential sites are utilized, and how the
synthesis and transport of E2 proteins lacking oligosac-
charides are affected in this system. Although E2660 is not
representative of the form of E2 incorporated into native
E1–E2 complexes (Clayton et al., 2002; Op De Beeck et
al., 2001), its ability to traverse the secretory pathway and
be modified into higher MW secreted forms (Michalak et
al., 1997) suggests that glycosylation events which accom-
pany this process reflect their importance for formation of
a correctly folded protein (Ellgaard and Helenius, 2003).
Results of our study indicate that proper expression of the
E2 protein in this system is dependent on the presence of
at least eight N-linked glycans, each of which contributes
to some extent to the processing and maturation of a
secreted form of the protein and integrity of its antigenic
properties.Results
Construction and properties of the E2 expression system
In initial experiments, an RT–PCR-derived clone of the
E1–E2 region of an HCV genotype 1a strain was used to
establish requirements for expression of the E2 protein. The
amino acid sequence of the genotype 1a E2 clone wasprotein. Numbers indicate the amino acids positions of each site. Asterisk
of some HCV strains.
Fig. 5. Expression of E2660 proteins containing multiple mutations. Cells
were transfected and proteins analyzed as described in Fig. 3. Top panel
indicates results in BHK cells. Bottom panel indicates results in Huh-7 cells.
Fig. 4. Expression of N-linked glycosylation mutants in BHK cells. Cells
were transfected with plasmid DNAs and proteins immunoprecipitated from
lysates as described in Materials and methods. Proteins were analyzed on
12% SDS polyacrylamide gels. Panel A indicates intracellular protein for
the parental E2660 protein (WT) and mutants N1 through N5 (top) and
secreted protein (bottom). M indicates mock-transfected cells. Panel B
indicates intracellular protein for parental and mutants N6 through N10
(top) and secreted protein (bottom).
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84%, respectively). This clone contained 10 potential N-
linked glycosylation sites. Expression of this E2 protein was
examined by constructing various pcDNA3.1-based plas-
mids encoding the E2 region with an amino-terminal signal
sequence derived from the E1 region and with different
carboxy termini (Fig. 1A). The carboxy termini were
positioned at amino acid 660, 715, or 746 of the HCV open
reading frame, corresponding to residues 276, 331, or 362 ofthe E2 open reading frame, respectively. These positions
were based on previous studies of others which showed that
a truncated E2661 protein was able to traverse the secretory
pathway and undergo proper folding more efficiently than
longer forms (Flint et al., 1999b, 2000; Matsuura et al.,
1994; Michalak et al., 1997; Spaete et al., 1992).
In cell-free translation experiments in the presence of
microsomal membranes, the E2715 protein was synthesized
and underwent apparent signal peptide cleavage and core
glycosylation, indicating that the initial stages of entry into
the secretory pathway were properly achieved by this
protein (Fig. 1B). Similar results were obtained with the
E2660 protein (data not shown). Core glycosylation resulted
in an increase in the apparent MW of the E2715 protein of
approximately 68 kDa, consistent with modification by as
many as 11 asparagine-linked oligosaccharides, as predicted
by the primary sequences of various HCV strains (Roggen-
dorf et al., 1993). Fig. 1C illustrates the expression of the
engineered E2 proteins in BHK cells. E2715 and E2660
constructs produced proteins of MWs 62 and 56 kDa,
respectively, whereas the E2 construct produced a protein
of MW 60 kDa. This appeared smaller in MW than E2715
perhaps because of anomalous migration caused by the
hydrophobic carboxyl-terminus contributed by the TM
region. The E2715 and E2660 constructs also produced
secreted forms of E2 which were recoverable from the
media as diffusely migrating proteins exhibiting MWs of
74 and 65 kDa, respectively, whereas E2 was not secreted.
The amount of E2715 recovered was very low compared to
Fig. 6. Expression of N-linked glycosylation mutants in Huh-7 cells. Cells
were transfected with plasmid DNAs and proteins immunoprecipitated from
lysates as described in Materials and methods. Proteins were analyzed on
12% SDS polyacrylamide gels.
Table 1
Summary of N-linked mutants of E2660
Construct Sizea Secretionb Predicted positionc
BHK Huh-7 BHK
E2660 NA NA +++
N1 1 1 ++ Very exposed
N2 1 1 ++ Buried
N3 1 1 ++ Very exposed
N4 1 1 ++ Very exposed
N5 1 1 ++ Exposed
N6 1 1 ++ Buried
N7 1 1 ++ Exposed
N8 1 1 ++ Very exposed
N9 0 0 ++ Very exposed
N10 0 0 ++ Mostly buried
N1+N2 2 2 +
N1+N3 2 2 +
N5+N6 2 2 +
N7+N8 2 2 +
N1!N3 3 3 +
N1!N4 4 4 
N5!N8 4 4 
N1!N8 8 8 
a Size indicates reduction in number of N-linked glycans relative to the
E2660 protein.
b Secretion based on estimates of relative amounts of protein recovered
from media of transfected cells.
c Predicted position of the N-linked acceptor site based on the model of
Yagnik et al., 2000.
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E2715 proteins lacking the ER retention signal characteristic
of the E2 protein as previously described by Michalak et al.
(1997). E2 proteins lacking an N-terminal signal sequence
were poorly expressed in our system (data not shown). E2
proteins from cells labeled in the presence of tunicamycin
(Panel D) revealed that the MWs of the E2715 and E2660
proteins were reduced to approximately 39 and 34 kDa,
respectively, consistent with what is predicted for the
corresponding regions of the E2 open reading frames
attached to the c-myc and polyhistidine tags. The E2 protein
migrated as two bands of MWs 38 and 35 kDa, respectively,
less than the predicted size of 43 kDa, presumably because
of aberrant migration or partial degradation of the unglyco-
sylated form. Tunicamycin treatment abolished secretion of
the E2715 and E2660 proteins into the media.
To further characterize E2 proteins, intracellular and
secreted forms of the proteins were subjected to digestion
with endoglycosidase F or H (Fig. 2). For the parental cell-
associated E2660 protein, treatment with these enzymes
reduced the MW to 36 and 37 kDa, respectively, andintermediate digestion products were observed in the case
of endo F digestion (Fig. 2, top panel). For the E2715
protein, a similar effect was observed with the endo F-
and endo H-treated forms migrating with apparent MWs of
42 and 43 kDa. For the E2 protein, the endo F and endo H
digestion products migrated with MWs of 41 and 42 kDa.
Analysis of the carbohydrates present on the secreted form
of the E2660 protein was also undertaken (Fig. 2, lower
panel). Comparison of the intracellular and secreted forms
of E2660 revealed that the latter was resistant to endoglyco-
sidase H digestion, consistent with the acquisition of com-
plex-type carbohydrates upon maturation through the
secretory compartment. E2715 was secreted into the media
in low levels, and characterization of endoglycosidase H
resistance on this form was inconclusive. Collectively, these
data indicate that the E2 protein expressed in this system
resembles that of other systems which have characterized
this protein (Dubuisson et al., 1994; Lanford et al., 1993;
Lucas et al., 2003; Matsuura et al., 1994; Ralston et al.,
1993; Tsitoura et al., 2002). The presence of c-myc/poly-
histidine tags used for detection of E2 did not seem to
adversely affect its properties.
Analysis of N-linked glycosylation site mutants
To determine which of the 10 predicted N-linked glyco-
sylation sites were used for modification of the E2660
protein, a series of mutations were engineered at each N-
linked site individually and in various combinations (Fig. 3).
Fig. 7. Expression of E2715 and E2 proteins containing mutations at N-
linked sites N9 and N10. Proteins were expressed as described in Figs. 3
and 4 and analyzed on 12% SDS gels. 746 indicates the E2 protein. Top
panel indicates results for BHK cells. Bottom panel indicates results for
Huh-7 cells. Migration of E2660 and its N2 and N1 + N2 mutants is shown
for comparison.
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X–T acceptor site was modified by replacement with an
alanine residue. The E2660 construct was initially used for
analysis of the effects of these mutations because the
synthesis and secretion of this protein were more efficient
than that of E2715, and others have reported that this form of
E2 attains a conformation that is consistent with a properly
folded protein (Michalak et al., 1997).
Analysis of E2660 proteins containing single mutations
at the N-linked glycosylation sites revealed that each of the
first eight predicted sites (N1 through N8) was utilized for
the addition of carbohydrate when analyzed by transient
expression in BHK cells (Figs. 4A and B, top panels). This
conclusion is because each of the mutants N1–N8
exhibited a small decrease in MW of approximately 2
kDa, consistent with the loss of a single N-linked oligo-
saccharide. However, mutants N9 and N10 did not appear
to undergo this decrease in MW, suggesting that these sites
were not utilized in this protein. Introduction of the single
mutations also did not adversely affect the levels of
expression of the cell-associated E2660 proteins, as judged
by the generally similar levels of the proteins detected in
this assay. Each E2660 protein containing a single mutation
produced slightly less of the soluble form of E2660 in themedia compared to that of the parental protein, except for
mutants N9 and N10 (Figs. 4A and B, bottom panels).
This suggests that elimination of even a single N-linked
glycan causes a mild impairment in the transport of E2660
through the secretory pathway.
We next examined the effects of combining mutations at
different N-linked sites on the expression and processing of
E2660, as shown in Fig. 5 (top panel). All proteins containing
two or three mutations (N1 + N2 + N3; N5 + N6; N7 + N8,
N1 + N2 [see Fig. 7 below], or N1 + N3 [data not shown])
were readily detectable, but the apparent MWs of these
mutant proteins were reduced in proportion to the number
of N-linked sites eliminated (approximately 4 kDa for loss of
two sites, and 6 kDa for loss of three sites). Production of the
soluble extracellular forms of these mutant proteins was
markedly reduced (Fig. 5, top panel). A further series of
mutant proteins containing ablation of four (N1-4 or N5-8) or
eight (N1-8) of the N-linked glycans were next analyzed.
Mutant E2660 proteins lacking four sites (N1-4 or N5-8)
exhibited reductions in apparent MWs to 48 kDa, consistent
with the loss of four N-linked glycans. The mutant E2660
protein lacking all eight N-linked sites (N1-8) was readily
detectable and migrated with an apparent MW of 36 kDa,
consistent with the results of tunicamycin treatment and
endoglycosidase digestions (Figs. 1 and 2). None of the
mutant proteins lacking four or more N-linked glycans was
recovered from the media. These data suggest that loss of
four or more of the glycans is very deleterious for transport
of the E2660 protein through the secretory pathway.
Expression in Huh-7 cells
To determine if utilization of the N-linked sites on E2660
is influenced by the cell type used for expression, the
mutants were also analyzed in Huh-7 cells. These cells
were chosen to more accurately reflect the processing of E2
proteins in a hepatic cellular environment. Results of these
experiments are shown in Fig. 6. Similar to the results in
BHK cells, the single glycosylation mutants N1 through N8
migrated with apparent MWs consistent with the loss of one
N-linked glycan (Fig. 6, top and middle panels). As ob-
served in BHK cells, mutants N9 and N10 appeared to
comigrate with the parental E2660 protein (Fig. 6, middle
panel), suggesting that these sites are not utilized in Huh-7
cells. Mutants N1-3, N1-4, N5-8, and N1-8 also exhibited
MW differences from E2660 which were similar to those
observed in BHK cells (Fig. 6, bottom panel). In the case of
Huh-7 cells, multiple additional bands were observed for the
parental and mutant forms of E2660. Although some of these
represented proteins from mock-infected cells, the lower
molecular weight forms may represent partially glycosy-
lated proteins, or even the unglycosylated 36-kDa E2
polypeptide. These observations suggest that glycosylation
of E2 in Huh-7 cells may be less efficient than BHK cells.
The secretion of the E2660 protein and the N-linked mutants
in Huh-7 cells were also generally similar to what was
Fig. 8. Immunofluorescence analysis of glycosylation mutants with anti-HCVantibodies. Huh-7 cells were transfected with plasmids encoding the E2 proteins
and prepared for indirect immunofluorescence as described in Materials and methods. Panel A indicates results with the parental (E2660) and N1–N8 mutant
E2(N1-8)660 as analyzed with anti-histidine (red) or polyclonal anti-recombinant E2 (green). Magnification is 600. Panel B compares parental E2660, E2(N1-
8)660 with E2(N1-4)660 and E2(N5-8)660, using the same antibodies as in panel A. Magnification is 400.
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these results suggest that modification of the E2660 protein
by N-linked glycosylation occurs in a similar manner in
both BHK and Huh-7 cells. The results of expression
experiments for BHK and Huh-7 cells are summarized in
Table 1.
Analysis of N-linked sites 9 and 10
Because expression of E2660 proteins containing single
mutations at sites N9 and N10 indicated that these sites werenot utilized (Figs. 3B and 5), studies were then done to
determine if utilization occurred in the context of the longer
proteins E2715 or E2. Fig. 7 shows the results of these
experiments. When compared to their parental proteins,
E2715 and E2 proteins containing mutations N9 and N10
exhibited apparent MWs that were smaller by approximately
2 kDa, suggesting that one or possibly both of these sites are
utilized in the longer forms of the proteins. These results
indicate that the length of the E2 protein can affect the
utilization of N-linked sites 9 and 10 in this expression
system both in BHK and Huh-7 cells. This may reflect
T. Slater-Handshy et al. / Virology 319 (2004) 36–48 43differences in the availability of these sites for glycosylation
in E2660 vs. E2715 and E2, or a requirement that these sites be
glycosylated in the larger E2715 and E2 proteins to facilitate
folding of the additional carboxy-terminal segments.
Immunofluorescence analysis of E2660 and N1-4, N5-8, and
N1-8 mutants
The absence of N-linked carbohydrates on the E2660
protein might be expected to impair or eliminate the
integrity of its antibody epitopes as a result of loss of
conformational stability. As an approach to this question,
expression of the parental E2660 protein and the N1–N8
mutant was examined in Huh-7 cells using immunofluores-
cence (Fig. 8A). In these experiments, the anti-polyhistidine
antibody was used to detect the total amount of parental or
mutant proteins expressed in the transfected cells, and a
polyclonal goat antibody to E2 (recombinant E2, genotype
1a produced in CHO cells, [Virostat, Inc.]) was used to
monitor the presence of E2-specific epitopes. In separate
experiments, these antisera were found to be reactive against
E2660 by immunoprecipitation under different detergent
conditions (data not shown), but fluorescence was a more
sensitive assay.
Both the parental E2660 protein and the N1–N8 mutant
were readily detected in Huh-7 cells with anti-his antibody
with a diffuse cytoplasmic staining pattern observed for
these proteins (Fig. 8A). Using the anti-E2 antibody, the
parental E2660 protein was detectable in essentially all of
those cells positive by anti-his antibody, although the
intensity of fluorescence varied somewhat from cell to
cell. In contrast, antiserum to E2 was not able to detect the
N1–N8 mutant in any of the cells that were positive with
anti-his antibody.
To determine if all of the N-linked glycans N1 to N8
were required for formation of E2 epitopes recognized by
the anti-E2 antisera in this assay, the two mutant E2660
proteins lacking either glycans N1–N4 or N5–N8 were then
analyzed. Compared to the parental E2660 protein, the N1-4
mutant exhibited a mildly reduced level of fluorescence,
whereas the N5-8 mutant exhibited a markedly reduced
fluorescence, but above the level produced by the N1-
8 mutant (Fig. 8B). The N1–N4 and N5–N8 mutant
proteins were readily detectable with antisera to the poly-
histidine tag, indicating that reduction in the levels of
expression of these protein did not account for their dimin-
ished reactivity with the antisera to E2. These results
suggest that N-linked glycans on E2 contribute to the
integrity of antibody epitopes on this protein.Discussion
In this study, expression of HCV E2 glycoproteins in
transiently transfected cells was used to determine the
utilization of its potential N-linked glycosylation sites andassess the importance of these glycans for processing and
maturation of E2 in the secretory compartment. Based on
the primary sequence of the E2 clone, 10 conserved poten-
tial N-linked sites were available, which is generally con-
sistent with the structure of E2 based on comparisons of
sequence data for different HCV isolates. Some isolates also
contain a potential site at polyprotein position 476–478,
which can be utilized, and at position 532–534 (Patel et al.,
2000). Similar to results of other studies which have
examined the expression of E2, we observed that the full-
length form of E2 (E2) was retained in the cell, whereas
truncated forms (E2660 and E2715) were recoverable both as
cell-associated and secreted forms, with the E2660 protein
undergoing more efficient secretion from the cell than
E2715. The core glycosylation of the E2 protein was mem-
brane-dependent, required an amino-terminal signal se-
quence, and involved addition of approximately 20 kDa of
carbohydrate, consistent with glycosylation at as many as
8–10 N-linked sites. Studies of N-linked glycans on cell-
associated forms of E2 have shown that they are sensitive to
endoglycosidase H digestion and therefore not modified into
complex carbohydrates (Dubuisson et al., 1994; Lanford et
al., 1993). Consistent with this, we observed that the E2660,
E2715, and E2 proteins in BHK cells were sensitive to this
enzyme. The failure to detect endoglycosidae H-resistant
forms of E2660 and E2715 despite the presence of such forms
in the media may indicate that intracellular levels of the
resistant forms are very low due to inefficient modification
in the Golgi compartment or rapid secretion after acquisition
of complex carbohydrates. In any case, the data indicate that
the E2 proteins we engineered for this study exhibited
expected features based on current studies in the literature.
The E2660 protein was initially used to characterize the
utilization of N-linked sites in our experiments because
efficient secretion of this truncated form from the cell allows
an indirect assessment of the integrity of its folding (Micha-
lak et al., 1997). Mutagenesis of the 10 potential N-linked
glycosylation sites on this protein revealed that each of the
first eight predicted sites was implicated in the addition of
an oligosaccharide chain. This is consistent with previous
studies demonstrating that the E2 protein expressed by itself
is a heavily glycosylated protein (Dubuisson et al., 1994;
Lanford et al., 1993). The utilization of N-linked sites 9 and
10 was not observed for the E2660 protein, but at least one of
these sites was modified in the context of E2715 and E2.
This may reflect a lack of accessibility of these N-linked
sites in the E2660 protein to the ER-associated oligosaccha-
ride transferase as a result of effects conferred by the
truncated carboxy terminus. Alternatively, there could be
an inhibitory effect of the c-myc and polyhistidine epitope
tags on glycosylation at these sites, although these tags did
not appear to interfere with glycosylation of the E2715 and
E2 proteins at positions N9 or N10. In terms of effects of N-
linked glycosylation sites on E2 expression and processing,
elimination of single or multiple sites had no obvious effect
on the level of intracellular E2 protein produced, but did
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transported through the secretory pathway. Proteins contain-
ing single mutations were all recoverable from the media,
but the levels were mildly reduced compared to that of the
E2660 parental protein. The decrease in secretion did not
appear to vary as a function of which individual N-linked
site was eliminated. Proteins lacking two or three N-linked
glycans exhibited markedly reduced secretion from the
cells, and proteins lacking four or more glycans failed to
be secreted. Because the ability to traverse the secretory
pathway implies formation of a properly folded glycoprotein
(Ellgaard and Helenius, 2003; Ellgaard et al., 1999), these
data suggest that the loss of even a single N-linked glycan at
positions 1 through 8 has a deleterious effect on the folding
and maturation of E2660. Because no single mutation was
able to abolish secretion, there may be no dominant effect of
any one of the N-linked glycans on the folding process of
E2660 in this system, similar to results observed in various
studies of other multiply glycosylated viral membrane
glycoproteins such as the hemagglutinin protein of some
subtypes of influenza (Gallagher et al., 1992; reviewed in
Doms et al., 1993). However, additional studies with more
sensitive assays of the folding and function of the HCV E2
protein may yet reveal effects of individual N-linked gly-
cosylation sites on its properties. Combinations of two N-
linked site mutations consistently reduced the secretion of
E2660 to low levels. This suggests additive or synergistic
contributions of glycans towards the folding and transport of
E2, at least for those combinations tested (N1 + N2, N1 +
N3, N5 + N6, or N7 + N8). However, it is possible that
other combinations of two mutations might actually abolish
the transport and secretion of E2660.
The data presented here must be interpreted with caution
in terms of implications about the importance of glycosyl-
ation for folding of the E2 protein. The properties of E2
expressed as a single protein are different from those of E2
incorporated into E1–E2 complexes. This may include
differences in conformational epitopes that are influenced
by the interaction of E2 with E1, and which might exist
only on the native infectious form of the virus (Clayton et
al., 2002; Owsianka et al., 2001; Triyatni et al., 2002;
Weiner et al., 2000). In addition, truncated forms of E2
which lack the transmembrane region are incompetent for
the formation of noncovalently bound E1–E2 complexes,
presumably because of the role of the transmembrane
regions in the proper folding of E1 and E2, and possibly
because of perturbations of ectodomain interactions which
may influence association of these proteins. The data we
have generated on N-linked glycosylation are therefore not
necessarily reflective of events involved in HCV virion
assembly, because this process involves budding of E1–E2
complexes containing full-length proteins into the ER
lumen. However, our findings may reflect to some extent
the requirements for N-linked glycans during early folding
events of E2 in the ER, which are dependent on interac-
tions with chaperones specific for proteins bearing partiallyglucosylated N-linked oligosaccharides, and therefore may
be important in the formation of some conformational
antibody epitopes.
In a structural model for E2 based on homology modeling
with the flavivirus tick-born encephalitis virus (TBEV)
envelope protein, the positions of the 11 potential N-linked
glycan sites on this molecule were predicted (Yagnik et al.,
2000). The data from our study are largely in agreement with
these predictions, because we observed that glycosylation
occurs at sites N1, N2, N3, N4, N5, N7, and N8, which
correspond to polyprotein residues 417–419, 423–425,
430–432, 448–450, 532–534, 556–558, and 576–578,
respectively, in the model. However, the model predicted
that sites N2 and N6 (polyprotein positions 423–425 and
540–542) were buried, whereas we provide evidence to
indicate that these sites are in fact utilized for glycosylation.
Discrepancies with the model for sites N2 and N6 may reflect
the inability of the model to accurately predict the local
structure of E2 in these regions due to low overall homology
with the TBEV envelope protein upon which the model is
based. Sites N9 and N10 correspond to polyprotein positions
623–625, which is predicted to be very exposed, and 645–
647, which is predicted to be mostly buried in the model.
Because we could not distinguish which of these two sites is
utilized in the E2715 and E2 proteins, conclusions about these
positions cannot be made at this time. However, the model
suggests that site N9 is most likely the site which is utilized.
A number of studies have analyzed the properties of
truncated and full-length E2 proteins for their antigenic
features and capacity to bind to the CD81 molecule
(Chan-Fook et al., 2000; Clayton et al., 2002; Flint et al.,
1999a, 1999b, 2000; Hadlock et al., 2000; Owsianka et al.,
2001; Petracca et al., 2000; Wunschmann et al., 2000). It
has been shown that truncated forms such as E2660 differ
from full-length E2 and E2 produced in association with E1
in the context of virus-like particles or even virion particles,
with respect to many features. These include reactivity with
conformation-sensitive monoclonal antibodies (Clayton et
al., 2002), ability to bind either to the large extracellular
loop of CD81 or to intact cells expressing this protein
(Triyatni et al., 2002; Wunschmann et al., 2000), and to
be inhibited from binding to CD81 (Owsianka et al., 2001).
Moreover, cell-associated E2661 differs antigenically from
the secreted form and is less able to bind CD81, in part as a
result of differences in the processing of N-linked carbohy-
drates (Flint et al., 2000). The factors that govern the
different behavior of the various forms of E2 in these
experiments are not well understood. Variations in primary
structure can clearly affect the antigenic and functional
properties of E2 (Patel et al., 2000), but utilization of N-
linked glycans and their modification into high mannose and
complex forms may also contribute. Our data indicate that
truncated and full-length forms of E2 differ in their utiliza-
tion of N-linked sites 9 or 10 (residues 623–625 and 645–
647, respectively), which lie in a region of E2 implicated in
the formation of high molecular weight aggregates, and
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(Flint et al., 2000; Patel et al., 2000). The possibility exists
that lack of these glycans on the truncated E2660 protein is in
part responsible for structural differences that distinguish
this protein from full-length E2 in the various receptor
binding assays. In some cases, the absence of N-linked
glycans on a glycoprotein can affect processing of oligo-
saccharides on adjacent glycans, which might affect its
functional properties (Roberts et al., 1993).
N-linked glycosylation has an important role in the
folding and maturation of viral envelope proteins by pro-
moting the proper formation of their ectodomains during
entry into the ER lumenal environment. The acquisition of
N-linked glycans confers the capacity to interact with ER
chaperones which are involved in regulating the exit of
nascent proteins from the ER. These interactions require the
presence of partially glucosylated oligosaccharides which
are trimmed and reglucosylated by UDP-glucose/glycopro-
tein glucosyltransferase during cycling of incompletely
folded proteins within the ER. In this respect, some glyco-
proteins are critically dependent on the presence of single
glycans to enable this process. The complicated nature of
E1–E2 complex formation, with its long halftime of for-
mation, and the intricate nature of protein–protein interac-
tions required for proper formation of the E1–E2 complex
support the notion that multiple N-linked glycosylation
events would have an important functional role. However,
the limited effects of single mutations on the secretion of the
E2660 protein suggest that individual glycans have minor
effects on the folding of E2. In this sense, we suggest that
the function of multiple N-linked glycans may be to
contribute locally to the conformational stability of E2,
which is slowly driven by prolonged interactions with the
ER chaperones. This has also been suggested for other viral
glycoproteins (Gallagher et al., 1992; Roberts et al., 1993).
Further experiments to examine the interactions of N-linked
E2 mutants with these chaperones are needed to substantiate
this hypothesis. Additional studies are also needed to
determine if the effects we have observed for N-linked
glycans on E2660 are similar to effects on the assembly of
native E1–E2 complexes. Other functions of multiple
glycans may include effects on reducing accessibility of
antibody to epitopes on the virion surface, as well as
affecting the interaction of HCV particles with cell-surface
molecules during the process of virus entry. Studies of
engineered HCV-like particles lacking specific N-linked
glycans in in vitro systems of neutralization and binding
to cellular receptors may yield insights into the existence
such additional functions.
The E2660 protein could be readily detected by immuno-
fluorescence in Huh-7 cells using antisera to recombinant
E2. It is not known if the epitopes detected with these
antisera represent native E2 epitopes, and further experi-
ments with conformation-sensitive monoclonal antibodies
are needed to assess the antigenic integrity of E2660 and its
N-linked glycan mutants. However, the lack of reactivity ofthe antisera with the unglycosylated N1–N8 mutant and
reduced reactivity with the partially glycosylated forms
N1–N4 and N5–N8 indicate that the N-linked glycans
appear to be required for the formation of some antibody
epitopes on E2660. This is presumably related to the role of
these residues in facilitating the interactions of E2 protein
with the ER chaperones required for proper folding of the
nascent protein, and suggests that multiple N-linked glycans
are necessary for acquisition of the epitopes. Further studies
are needed to determine how dependent the formation of the
antigenic structure of properly folded E1–E2 native com-
plexes is on the presence of multiple glycans, particularly if
they are required for maintaining the antigenic structure of
these complexes after they are properly assembled. Such
information may have implications for the design of subunit
vaccine modalities for eliciting antibodies against HCV
based on expression of E1–E2 complexes.Materials and methods
Cells and viruses
BHK-21 cells were obtained from the ATCC and grown
in minimal essential medium containing 10% fetal bovine
serum and penicillin-streptomycin. Huh-7 cells were pro-
vided by Dr. John Tavis (Saint Louis University) and grown
in 50:50 Dulbecco’s minimal essential medium (DMEM;
Life Technologies) and F12 supplemented with 10% fetal
bovine serum. A vaccinia virus recombinant expressing the
T7 DNA polymerase, vTF7-3, was used for transient
expression assays. This virus was used as described previ-
ously (Chambers et al., 1993).
Plasmid constructions
A pBluescript II plasmid (Stratagene) containing a 1700-
base pair fragment consisting of the E1/E2 region was
initially constructed. The cDNA for the E1–E2 region was
derived by RT–PCR using RNA prepared from a serum
specimen of a patient chronically infected with a 1a genotype
virus. The RT reaction was done using a primer
corresponding to nucleotides 2641–2665 in the presence of
Superscript II (Gibco). First round PCR was done with
primers corresponding to nucleotides 819–841 and 2631–
266, and second round PCR was done using primers
corresponding to nucleotides 852–873 and 2530–2551,
containing EcoRI and HindIII restriction sites. The PCR
product was purified using a Quiagen Spin Kit, digested with
EcoRI and HindIII, and cloned into pBluescript-KS(II) after
digestion with the same enzymes. The resulting clones were
verified by nucleotide sequencing and used for further con-
structions. The sequence has been submitted to GenBank
(accession number AY388455). The E2 region with its
corresponding signal sequence was amplified by PCR using
Deep Vent DNA polymerase (New England Biolabs) and a
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terminal signal sequence of E1 (sig) and an E2 open reading
frame of varying lengths (Fig. 1). SigE2660 is a truncated
version of E2 that ends at amino acid 276 within the E2
protein. SigE2715 ends at amino acid 331, and sigE2 contains
the E2 reading frame up to residue 362. Each PCR product
was subcloned into the pCR-Blunt-TOPO plasmid vector
(Invitrogen) and subsequently inserted into pcDNA3.1/myc-
His(-) using NheI and KpnI restriction sites. All expression
constructs contained the c-myc and polyhistidine epitopes
immediately downstream of the carboxy termini to facilitate
identification of proteins by immunoprecipitation or immu-
nofluorescence. All final plasmid constructs were verified by
nucleotide sequencing.
Site-directed mutagenesis
Single glycosylation site mutants were created using the
QuikChange Site-Directed Mutagenesis Kit (Stratagene).
Synthetic oligonucleotide primers were designed to replace
the Ser or Thr of the N-linked acceptor site (Asn-X-Thr/Ser
where X is any amino acid except Pro) with an Ala residue.
The mutants are designated by N1, N2, N3, etc. (N for the
Asn modification and the number of the glycosylation site
in the E2 protein). Multiple site mutants were generated by
sequential rounds of site-directed mutagenesis or by sub-
cloning fragments from plasmids containing the engineered
mutations using available restriction sites in the E2
region. The plasmids used for mutagenesis of the
N-linked sites were as follows. N1, 5V-GTAAACAG-
C A A C G G C G C C T G G C A C AT TA ATA G G - 3 V;
N2, 5V-CAGCT-GGCACATTAACAGGGCTGCCCT-
GAACTGC-3V; N3,5V-CTGAACTGCAACGACGCCCTC-
CACACCGGG - 3 V; N 4 , 5 V- CATAAGTTCAA -
CGCGGCCGGATGTCCAGAGC - 3 V; N 5 , 5 V- 5 V
GATGGGGGGAGAATGAGGCGGACGTGCTGCTCC-3V;
N6, 5V-CTGCTCCTCAACAACGCGCGCCCACCG-
C A AG G C A A C - 3 V; N 7 , 5 V- C G T G GAT GA A -
TAGCGCTGGGTTCACCAAGAC - 3 V; N 8 , 5 V-
GGGTTGGTAACAACGCGTTGACTTGCCCTACGG-3V;
N9, 5V-CTGCACTGTCAACTTCGCCATCTTCAAGGT-
TAG-3V; N10, 5V-CTGCATGCAACTGG-GCCCGAGGG-
GAGCGCTG-3V.
Cell-free translation
Translation was performed using the TNT system (Prom-
ega). Reactions were programmed with 1 Ag of plasmid DNA
in 25-Al volumes in the presence of components as recom-
mended by the manufacturer, including 1.5 Al of canine
pancreatic microsomal membranes and 35[S]-methionine
(Amersham) at 10 ACi/reaction. Control reactions for mem-
brane-dependent core-glycosylation and signal peptide pro-
cessing were run using reagents supplied by the
manufacturer. Translation was carried out at 30 jC for 90
min, following which samples were solubilized in an equalvolume of 2 Laemmli sample buffer by heating at 70 jC for
30 min. Translation products were analyzed on 12% SDS
polyacrylamide gels.
Transient expression assay
BHK-21 cells grown to 90–95% confluency in 35-mm
dishes were infected with vTF7-3 at a multiplicity of approx-
imately 10 PFU per cell. After 30 min, the inoculum was
removed, the cells were washed, and 1 ml of minimal
essential medium containing 1 Ag plasmid DNA, 4 Al of
lipofectamine, and 6 Al of PLUS (Life Technologies) was
added, and the cells were incubated at 37 jC for 2.5 h. The
transfection mixture was removed, the cells washed, and
minimal essential medium containing 1/40th the normal
concentration of methionine, 5% fetal bovine serum, and
35[S]-methionine label (40 microCi/ml) was added for 5 h.
Lysates and supernatants were then prepared for immunopre-
cipitation. For transient expression assays in Huh-7 cells,
cells were grown to 80% confluency and infected with vTF7-
3 as described above. DMEM/F12 (1 ml) containing 2 Ag
DNA and 20 Al lipofectin (Life Technologies) was added and
the cells were incubated for 2–2.5 h. Cells were then labeled
as described previously. E2 expression was examined in cell
extracts and media as described below.
Immunoprecipitation and gel electrophoresis
Labeled cells were lysed with 1% sodium dodecyl sulfate
(SDS) in 0.1 M Tris (pH 7.5), 0.3 M NaCl, and 2 mM
EDTA containing 20 Ag/ml of phenylmethylsulfonyl fluo-
ride. Lysates were sheared through a 26-gauge syringe,
heated at 70 jC for 10 min, and centrifuged at 14,000
RPM for 5 min in an eppendorf microcentrifuge. Super-
natants were collected, diluted 1:1 with 2 TNA (1% Triton
X-100, 0.1 M Tris pH 7.5, 2 mg/ml BSA, and 2 mM
EDTA), then diluted 1:1 with 1 TNA, and 2 Al each of
anti-c-myc and anti-his antibodies (Invitrogen) were added.
Reactions were incubated for 12 h at 4 jC on a shaker and
the immune complexes were collected using Staphylococcus
aureus Cowan strain I (Calbiochem). Immunoprecipitates
were washed three times with 1 TNA containing 125%
SDS followed by TNE (50 mM Tris pH 7.5, 1 M NaCl, and
1 mM EDTA). Proteins were recovered from the media by
adding Triton and SDS to final concentrations of 0.1% and
0.2%, respectively, and then anti-c-myc and anti-his anti-
bodies were added. Immune complexes were collected as
above but washed with 1 TNA and TNE containing 150
mM NaCl. Immunoprecipitates were solubilized in Laemmli
sample buffer, run on SDS-polyacrylamide gel electropho-
resis, and proteins were detected by autoradiography.
Endoglycosidase digestions
PNGase F and Endo H digestions were performed
according to the manufacturer’s protocols (New England
T. Slater-Handshy et al. / Virology 319 (2004) 36–48 47Biolabs). Cells were transfected and immunoprecipitated as
described above. The pellets were denatured in 1 glyco-
protein denaturing buffer (5% SDS, 10% h-mercaptoetha-
nol) at 100 jC for 10 min. The samples were centrifuged
at 10,000 rpm for 1 min in an Eppendorf microcentrifuge,
and the supernatants were transferred to new tubes. For
PNGase F digestion, 10 G7 Buffer (0.5 M sodium
phosphate pH 7.5 at 25 jC) and 10% NP-40 were each
added at 1/10 the volume of sample. PNGase F (1 Al) was
then added and the reaction was incubated at 37 jC for 1
h. The samples were then aliquoted into two tubes and
each diluted 1:1 with 2% SDS sample buffer. For Endo H
digestion, samples were denatured as described and 1/10
the volume of 10 G5 Buffer (0.5 M sodium citrate pH
5.5 at 25 jC) was added. Endoglycosidase H (1 Al) was
added and the reaction was incubated at 37 jC for 1 h.
Samples were aliquoted and diluted as described for
endoglycosidase F.
Immunofluorescence
Subconfluent monolayers of Huh-7 cells were transfected
as described above and processed by fixation in 4% para-
formaldehyde for 15 min, followed by permeabilization
with methanol at 20 jC for 5 min. Primary antibodies
(mouse monoclonal anti-his and anti-c-myc [Invitrogen], or
goat anti-recombinant E2 [Virostat]) were incubated with
the cells at dilutions of 1:1000 or 1:200, respectively.
Secondary antibodies (FITC-labelled rabbit anti-mouse or
rabbit anti-goat [ICN Pharmaceuticals]) were used at dilu-
tions of 1:500 or 1:250. Cells were analyzed by fluorescence
microscopy and photographed with a SPOT camera (Diag-
nostic Instruments).Acknowledgments
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